72.37

3.51% -2.63

Doximity Inc (DOCS)

Overview News Price History Option Chain Financials Why DOCS Down? Discussions Forecast

Doximity Inc stock is traded at $72.37, with a volume of 3.13M. It is down -3.51% in the last 24 hours and up +30.35% over the past month. Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Previous Close:

$75.00

Open:

$74.9

24h Volume:

3.13M

Relative Volume:

1.42

Market Cap:

$13.58B

Revenue:

$516.85M

Net Income/Loss:

$174.11M

P/E Ratio:

83.18

EPS:

0.87

Net Cash Flow:

$217.38M

1W Performance:

-6.10%

1M Performance:

+30.35%

6M Performance:

+98.65%

1Y Performance:

+149.38%

1-Day Range:

$71.59

$75.00

1-Week Range:

$71.59

$79.97

52-Week Range:

$22.96

$85.21

Doximity Inc Stock (DOCS) Company Profile

Name

Doximity Inc

Sector

Healthcare (1169)

Industry

Health Information Services (58)

Phone

(650) 549-4330

Address

500 THIRD STREET, SAN FRANCISCO

Employee

827

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

DOCS's Discussions on Twitter

Compare DOCS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DOCS Doximity Inc	72.37	13.58B	516.85M	174.11M	217.38M	0.87
VEEV Veeva Systems Inc	225.79	36.66B	2.66B	665.91M	1.08B	4.05
SOLV Solventum Corp	73.02	12.61B	8.26B	66.00M	1.17B	0.3682
TEM Tempus Ai Inc	68.09	10.72B	640.44M	-743.28M	-206.93M	-11.29
HQY Healthequity Inc	108.60	9.41B	1.15B	96.70M	-161.99M	1.09

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-07-25	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-07-25	Upgrade	Piper Sandler	Neutral → Overweight
Dec-20-24	Initiated	Stephens	Equal-Weight
Dec-04-24	Initiated	Mizuho	Neutral
Nov-15-24	Initiated	Goldman	Neutral
Nov-14-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-13-24	Downgrade	Canaccord Genuity	Buy → Hold
Nov-08-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Nov-08-24	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-15-24	Upgrade	Barclays	Equal Weight → Overweight
Aug-09-24	Upgrade	Needham	Hold → Buy
Jul-18-24	Downgrade	Wells Fargo	Equal Weight → Underweight
Apr-25-24	Upgrade	JP Morgan	Underweight → Neutral
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Jan-02-24	Upgrade	BofA Securities	Underperform → Neutral
Aug-09-23	Downgrade	Guggenheim	Buy → Neutral
Aug-09-23	Downgrade	Needham	Buy → Hold
Aug-03-23	Downgrade	Piper Sandler	Overweight → Neutral
May-01-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-31-22	Initiated	Wells Fargo	Overweight
Oct-24-22	Initiated	Evercore ISI	In-line
Oct-13-22	Initiated	BTIG Research	Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-05-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-28-22	Initiated	Berenberg	Buy
May-18-22	Reiterated	BofA Securities	Neutral
May-18-22	Reiterated	Goldman	Buy
May-18-22	Reiterated	Guggenheim	Buy
May-18-22	Reiterated	Jefferies	Buy
May-18-22	Reiterated	Morgan Stanley	Equal-Weight
May-18-22	Reiterated	Needham	Buy
Apr-07-22	Initiated	Guggenheim	Buy
Apr-04-22	Initiated	BofA Securities	Neutral
Feb-11-22	Initiated	Goldman	Buy
Dec-14-21	Downgrade	JP Morgan	Neutral → Underweight
Dec-02-21	Initiated	Jefferies	Buy
Nov-17-21	Initiated	Robert W. Baird	Outperform
Nov-10-21	Reiterated	Canaccord Genuity	Buy
Nov-10-21	Reiterated	Goldman	Neutral
Nov-10-21	Reiterated	Morgan Stanley	Equal-Weight
Nov-10-21	Reiterated	Needham	Buy
Nov-10-21	Reiterated	Piper Sandler	Overweight
Aug-26-21	Downgrade	JP Morgan	Overweight → Neutral
Jul-19-21	Initiated	Canaccord Genuity	Buy
Jul-19-21	Initiated	Goldman	Neutral
Jul-19-21	Initiated	JP Morgan	Overweight
Jul-19-21	Initiated	Morgan Stanley	Equal-Weight
Jul-19-21	Initiated	Piper Sandler	Overweight
Jul-19-21	Initiated	Raymond James	Outperform
Jul-19-21	Initiated	SVB Leerink	Outperform
Jul-19-21	Initiated	William Blair	Outperform

View All

Doximity Inc Stock (DOCS) Latest News

Feb 21, 2025

Rice Hall James & Associates LLC Sells 133,151 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Feb 21, 2025

Why Doximity’s Surging Stock is the Talk of Wall Street - MotoPaddock

Feb 21, 2025

Unlocking the Surge: How Doximity Became a Healthcare Powerhouse - Jomfruland.net

Feb 21, 2025

Doximity (DOCS) Demonstrated Strong Fundamentals in Q4 - Insider Monkey

Feb 21, 2025

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.’s Directors and Officers for Breach of Fiduciary Duties – DOCS - Business Wire

Feb 21, 2025

4,073 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Hardy Reed LLC - MarketBeat

Feb 21, 2025

Doximity, Inc. (NASDAQ:DOCS) Shares Bought by Venturi Wealth Management LLC - MarketBeat

Feb 21, 2025

State of New Jersey Common Pension Fund D Sells 6,893 Shares of Doximity, Inc. (NASDAQ:DOCS) - MarketBeat

Feb 21, 2025

9,628 Shares in Doximity, Inc. (NASDAQ:DOCS) Acquired by Sheaff Brock Investment Advisors LLC - MarketBeat

Feb 21, 2025

Feb 20, 2025

NYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Doximity, Inc. - ACCESS Newswire

Feb 20, 2025

Doximity, Inc. (NASDAQ:DOCS) Stake Lessened by Baillie Gifford & Co. - MarketBeat

Feb 20, 2025

Peering Into Doximity's Recent Short Interest - Benzinga

Feb 20, 2025

Feb 19, 2025